Jade Biosciences JBIO
NASDAQ JBIO
$19.91 +0.06 (+0.30%)
As of: Sep 4, 2026 · 3:59 PM EDT

Jade Biosciences (JBIO) Preferred Shares (2025 - 2026)

Jade Biosciences' (JBIO) quarterly Preferred Shares came in at $2000.0 in Q1 2026, little changed on a QoQ basis from $2000.0 in Q4 2025.

Analysis

Jade Biosciences (JBIO) Preferred Shares (2025 - 2026) Analysis & Trends

Jade Biosciences (JBIO) has 2 years of Preferred Shares data on file, last reported at $2000.0 in Q1 2026.

  • Quarterly Preferred Shares changed N/A year-over-year to $2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2000.0 (changed N/A YoY) and the FY2025 annual result came in at $2000.0, changed N/A from the prior year.
  • Preferred Shares was little changed at $2000.0 in Q1 2026, from $2000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $2000.0 in Q2 2025 to a low of $2000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Jade Biosciences 1.21 Bn 1.21 Bn - 2,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2,000.00
Mar 31, 2026 2,000.00
Dec 31, 2025 2,000.00
Sep 30, 2025 2,000.00
Jun 30, 2025 2,000.00